Oncology Biotech Sues Rival Over Cancer-Testing Patent
An American oncology biotechnology company has sued a Swiss rival for patent infringement, arguing that the medical software business' cancer test and "cutting-edge" platform to accurately analyze data about a patient's...To view the full article, register now.
Already a subscriber? Click here to view full article